Directorate Change

By

Regulatory News | 14 Jun, 2019

Updated : 07:04

RNS Number : 1725C
Honeycomb Investment Trust PLC
14 June 2019
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

 

 

Honeycomb Investment Trust plc (the "Company")

Director Appointment

 

The Company is pleased to announce the appointment of Richard Rowney as an independent non-executive director with effect from 1 July 2019. Richard will also be appointed as a member of the Audit and Risk, Management Evaluation and Remuneration and Nomination Committees of the Board from this date.  Richard has a wealth of experience in Financial Services and is currently the CEO of leading financial mutual LV=. Richard previously spent 14 years at Barclays Bank holding a number of senior positions across corporate and retail banking and is currently a Board member of the Association of British Insurers.

 

Commenting on his appointment, Robert Sharpe, the Company's Chairman said:

"I am delighted we have been successful in attracting a person of the calibre and experience of Richard to the Board.  I very much look forward to working with him to chart the continued success of the business".

There are no further details in respect of Richard Rowney requiring disclosure under Listing Rule 9.6.13.

 

 

 

For further information about this announcement please contact:

Link Company Matters Limited - Corporate Secretary

Paula O'Reilly

020 7954 9796

Pollen Street Capital

Chris Palmer / Steve Plowman

020 3728 6740 / 6761

Liberum Capital Limited

Chris Clarke / Louis Davies

020 3100 2000

 

 

14 June 2019

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFMGMVVFNGLZM

Last news